Divestiture

A new subcutaneous autoinjector for Alzheimer's drug Leqembi could soon transform care for millions in China, moving treatment from hospital to home.

The legal tech firm is cleared for trading after a two-month halt, now focusing on debt reduction using proceeds from a major UK asset divestiture.

Schweiter Technologies will unveil its 2025 results and 2026 strategy on Feb 27, with investors eager for signs of growth and profitability.

Fluent sells its Winopoly subsidiary to focus on its booming Commerce Media business, a strategic pivot aiming for long-term value amid a shifting AdTech landscape.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

Despite product withdrawals, a lack of regulation and the long latency of asbestos-related diseases mean the danger from talc exposure is far from over.

Positive study results for Alvotech's Entyvio biosimilar could disrupt the IBD market, promising lower costs for a blockbuster chronic care treatment.

Volvo Cars' Q4 profits fell, but a tough cost-cutting plan boosted cash flow, setting the stage for its critical electric vehicle push in a tough market.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Henkel's blockbuster acquisition of Stahl Group reshapes the specialty chemicals market, triggering a profitable, mandatory exit for minority shareholder Clariant.

The judge from the Trump civil fraud trial, Hon. Arthur Engoron, is moving to private arbitration, highlighting a major trend in the legal industry.

Access earns its fourth Best in KLAS award for data archiving, a win that underscores deep customer trust and the critical role of smart data management.

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

A retired anesthesiologist suffers a catastrophic brain injury during surgery. Now, her family is taking a major healthcare provider to trial for negligence.

After a brutal winter storm cut Bitcoin production, Cango Inc. is selling its crypto reserves to fund a strategic expansion into the booming AI market.

After orchestrating a major divestiture, Stoneridge's long-time CFO Matt Horvath resigns, ushering in a new era for the transportation tech firm.

Following a veteran executive's retirement, Salem Media elevates internal talent to steer key markets through a challenging financial and media landscape.

Over 1,100 groups are fighting to save federal funding for walking and biking, warning of dire safety and economic consequences if key programs are cut.